Single-dose Safety Study of APD916 in Healthy Volunteers
NCT01093508
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
72
Enrollment
INDUSTRY
Sponsor class
Conditions
Narcolepsy With or Without Cataplexy
Interventions
DRUG:
APD916
Sponsor
Arena Pharmaceuticals